133 related articles for article (PubMed ID: 26619843)
1. Expression and prognostic value of the aldehyde dehydrogenase 1 (ALDH1) and N-myc downstream regulated gene 2 (NDRG2) as potential markers in human astrocytomas.
Goudarzi PK; Mehrabi F; Khoshnood RJ; Bagheri AB; Ahmadi K; Yahaghi E; Abdolhoseinpour H
Tumour Biol; 2016 May; 37(5):6261-5. PubMed ID: 26619843
[TBL] [Abstract][Full Text] [Related]
2. ALDH1 expression is correlated with pathologic grade and poor clinical outcome in patients with astrocytoma.
Liu DY; Ren CP; Yuan XR; Zhang LH; Liu J; Liu Q; Yuan J; Yuan D; Jiang XJ
J Clin Neurosci; 2012 Dec; 19(12):1700-5. PubMed ID: 23084350
[TBL] [Abstract][Full Text] [Related]
3. Expression and prognostic value of NDRG2 in human astrocytomas.
Li L; Wang J; Shen X; Wang L; Li X; Liu Y; Shi M; Zhao G; Deng Y
J Neurol Sci; 2011 Sep; 308(1-2):77-82. PubMed ID: 21705028
[TBL] [Abstract][Full Text] [Related]
4. Combined aberrant expression of N-Myc downstream-regulated gene 2 and CD24 is associated with disease-free survival and overall survival in patients with hepatocellular carcinoma.
Li B; Shao Q; Ji D; Li F; Guo X; Chen G
Diagn Pathol; 2014 Oct; 9():209. PubMed ID: 25338637
[TBL] [Abstract][Full Text] [Related]
5. Decreased expression of NDRG2 is related to poor overall survival in patients with glioma.
Li W; Chu D; Chu X; Meng F; Wei D; Li H; Sun B
J Clin Neurosci; 2011 Nov; 18(11):1534-7. PubMed ID: 21872476
[TBL] [Abstract][Full Text] [Related]
6. Reduced N-Myc downstream-regulated gene 2 expression is associated with CD24 upregulation and poor prognosis in patients with lung adenocarcinoma.
Wang H; Wang W; Wang X; Cai K; Wu H; Ju Q; Huang Z; Gao X
Med Oncol; 2012 Dec; 29(5):3162-8. PubMed ID: 22528516
[TBL] [Abstract][Full Text] [Related]
7. Aldehyde dehydrogenase 1/epidermal growth factor receptor coexpression is characteristic of a highly aggressive, poor-prognosis subgroup of high-grade serous ovarian carcinoma.
Liebscher CA; Prinzler J; Sinn BV; Budczies J; Denkert C; Noske A; Sehouli J; Braicu EI; Dietel M; Darb-Esfahani S
Hum Pathol; 2013 Aug; 44(8):1465-71. PubMed ID: 23465277
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of ALDH1, EZH2 and Ki-67 in Astrocytic Gliomas.
Ahmed S; Rashed H; Hegazy A; Mohamed AM; Elmesallamy W
Turk Patoloji Derg; 2016; 32(2):70-81. PubMed ID: 27136105
[TBL] [Abstract][Full Text] [Related]
9. Manganese superoxide dismutase (MnSOD) is a malignant astrocytoma specific biomarker and associated with adverse prognosis in p53 expressing glioblastoma.
Shwetha SD; Shastry AH; Arivazhagan A; Santosh V
Pathol Res Pract; 2016 Jan; 212(1):17-23. PubMed ID: 26616112
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Impact of ALDH1 Expression in Transitional Cell Carcinoma of the Renal Pelvis.
Liu J; Jin J; Yang Y; Han W; Yu W; Shen C; Zhang N; Du P; Zhao Q; Wang S; Tang X
Anticancer Res; 2015 Sep; 35(9):4829-36. PubMed ID: 26254374
[TBL] [Abstract][Full Text] [Related]
11. Expression of NDRG2 in Human Colorectal Cancer and its Association with Prognosis.
Chen W; Peng J; Ou Q; Wen Y; Jiang W; Deng Y; Zhao Y; Wan D; Pan Z; Fang Y
J Cancer; 2019; 10(15):3373-3380. PubMed ID: 31293640
[No Abstract] [Full Text] [Related]
12. Expression of NDRG2 in human lung cancer and its correlation with prognosis.
Li SJ; Wang WY; Li B; Chen B; Zhang B; Wang X; Chen CS; Zhao QC; Shi H; Yao L
Med Oncol; 2013 Mar; 30(1):421. PubMed ID: 23307246
[TBL] [Abstract][Full Text] [Related]
13. Aldehyde dehydrogenase 1 expression is a predictor of poor prognosis in node-positive breast cancers: a long-term follow-up study.
Yoshioka T; Umekita Y; Ohi Y; Souda M; Sagara Y; Sagara Y; Sagara Y; Rai Y; Tanimoto A
Histopathology; 2011 Mar; 58(4):608-16. PubMed ID: 21371077
[TBL] [Abstract][Full Text] [Related]
14. Aldehyde dehydrogenase 1 expression predicts poor prognosis in triple-negative breast cancer.
Ohi Y; Umekita Y; Yoshioka T; Souda M; Rai Y; Sagara Y; Sagara Y; Sagara Y; Tanimoto A
Histopathology; 2011 Oct; 59(4):776-80. PubMed ID: 22014057
[TBL] [Abstract][Full Text] [Related]
15. Aldehyde Dehydrogenase 1 Expression Predicts Chemoresistance and Poor Clinical Outcomes in Patients with Locally Advanced Cervical Cancer Treated with Neoadjuvant Chemotherapy Prior to Radical Hysterectomy.
Xie Q; Liang J; Rao Q; Xie X; Li R; Liu Y; Zhou H; Han J; Yao T; Lin Z
Ann Surg Oncol; 2016 Jan; 23(1):163-70. PubMed ID: 25916979
[TBL] [Abstract][Full Text] [Related]
16. [Expression of candidate tumor suppressor gene N-Myc downstream-regulated gene 2 in colon cancer].
Chu DK; Zhang J; Shi H; Dong GL; Liu XP; Wang WZ
Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Jul; 11(4):354-7. PubMed ID: 18636358
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological significance of cancer stem-like cell markers in high-grade neuroendocrine carcinoma of the lung.
Morise M; Hishida T; Takahashi A; Yoshida J; Ohe Y; Nagai K; Ishii G
J Cancer Res Clin Oncol; 2015 Dec; 141(12):2121-30. PubMed ID: 25963795
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of NDRG2 and NDRG3 in prostate cancer patients undergoing radical prostatectomy.
Ren GF; Tang L; Yang AQ; Jiang WW; Huang YM
Histol Histopathol; 2014 Apr; 29(4):535-42. PubMed ID: 24222185
[TBL] [Abstract][Full Text] [Related]
19. Aldehyde dehydrogenase-1 predicts favorable prognosis in patients with vulvar squamous cell carcinoma.
Wu Q; Shi H; Holm R; Li X; Trope C; Nesland JM; Suo Z
Anticancer Res; 2014 Feb; 34(2):859-65. PubMed ID: 24511023
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of vascular adhesion protein-1 is associated with poor prognosis of astrocytomas.
Kostoro J; Chang SJ; Clark Lai YC; Wu CC; Chai CY; Kwan AL
APMIS; 2016 Jun; 124(6):462-8. PubMed ID: 26935340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
